Monday, August 3, 2020

EU HEALTHCARE & SOCIAL CARE NEWS

Innovation, technology, and evidence-based treatment for spinal cord injury

Innovation, technology, and evidence-based treatment for spinal cord injury

HEQ explores innovation in the treatment of spinal cord injury. Injuries to the spinal cord, whether they are caused by an acute trauma such as...
Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga has been shown to significantly reduce the worsening of renal function or risk of death in patients with chronic kidney disease with and...
Telehealth and mental health in lockdown

Telehealth and mental health in lockdown

Jo Hillier, Digital Clinical Lead at Sussex Partnership NHS Foundation Trust, speaks with HEQ about digital remote mental health support provision during the pandemic. Health...
Rising to the challenge of patient safety in a new era

Rising to the challenge of patient safety in a new era

Proactive patient safety and risk prevention are key to helping healthcare organisations surveil and mitigate global and local risks. Currently, the world is in crisis...
What happened to mobile tracking in the UK?

What happened to mobile tracking in the UK?

HEQ explores the failure to launch the NHS Track and Trace app. One key challenge for policymakers and healthcare authorities in countries affected by the...
Exploring applications of ultraviolet disinfection technology

Exploring applications of ultraviolet disinfection technology

HEQ explores some real-world applications of ultraviolet disinfection technology. UVC light energy in the germicidal wavelength range between 200nm and 280nm has an array of...
Currency UK: CBD, currency, and COVID-19

Currency UK: assessing the impact of COVID-19 on the CBD sector

Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector. With CBD still being a relatively...
Advocacy group launches Australian Medicinal Cannabis Course Online

Advocacy group launches Australian Medicinal Cannabis Course Online

The recent Senate recommendations to substantially increase medical cannabis education for health professionals are being implemented by a leading advocacy group with the launch...
Reduce esketamine price to manage treatment-resistant depression 

Reduce esketamine price to manage treatment-resistant depression 

Researchers are hoping their new paper will encourage policymakers, insurers, and healthcare leaders to work to reduce the price of esketamine nasal spray to...
Innovative antibiotics to be available for UK patients in world-first scheme

Innovative antibiotics to be available for UK patients in world-first scheme

A new scheme that starts this week is aiming to provide innovative antibiotics to NHS patients for the first time in almost 30 years...
Ensuring wellbeing and productivity in a healthcare workforce

Ensuring wellbeing and productivity in a healthcare workforce

Levell helps the healthcare workforce and leaders communicate about how they are feeling and what drives them, in order to increase wellbeing, protect quality,...
Innovating care pathways in 2020

Buddy Healthcare: innovating care pathways in 2020

Markus Lind, Chief Sales Officer at Buddy Healthcare, shows how surgery clinics can restart elective surgeries safely and automate care co-ordination processes. As the global...

Latest Publication

Health Europa Quarterly Issue 13

Welcome to Health Europa Quarterly Issue 13, which focuses – inevitably – on issues surrounding the Covid-19 pandemic, from the importance of hand hygiene...



Media Partners

EVENT PARTNERS

LATEST HEALTH EBOOKS

Introducing the Narrenturm: the world’s first hospital for the mentally ill

Before the end of the 18th century, those who were mentally ill were not regarded as patients, however in 1784 Austria, the Narrenturm was...

The BRoTHER project: promoting digitalisation in biobanking research

Improving personalised medicine by increasing digitalisation throughout the field of biobanking research, we present to you our partner brochure with: BRoTHER Biobanking is used in...

Living with mucopolysaccharidoses: support, awareness and research

Mucopolysaccharidoses (MPS) is a group of rare, inherited, incurable metabolic diseases caused by disorders in the metabolism, in this eBook the Austrian MPS Society...

The Institute for Cardiogenetics joining forces to promote cardiovascular research

With the aim of promoting innovative cardiovascular research, The Institute for Cardiogenetics are collaborating with VIAgenomics to translate years of knowledge into pioneering treatment. In...

LATEST PARTNERS

Easy, Low Cost, Legal Digital Transactions

California-based Artery Inc. provides easy, low cost banking alternatives and digital transaction services on blockchain to help business owners in cash heavy industries safely...

MPS Austria: champions of self-help support and research for therapy

Mucopolysaccharidoses (MPS) are slowly progressive and inheritable metabolic diseases and MPS Austria helps to improve quality of life for MPS patients. MPS diseases occur in...

Pharmacovigilance and life sciences services, brought to you by ProPharma Group

While covering six continents with their pharmacovigilance services, ProPharma Group are exceptionally committed to the safety of patients. ProPharma Group is an industry leader providing...

PillTime: the digital pharmacy using robotic technology

Discover the world of PillTime, the digital pharmacy that uses robotic technology to improve medication management in community and healthcare settings. When organising a lot...

MEDICAL CANNABIS NETWORK

First medical cannabis patient to receive funding for one year

First medical cannabis patient to receive funding for one year

Sapphire Medical Foundation has announced its first patient has secured medicine funding for one year. Two years following the rescheduling of cannabis-based medicinal products in...
Cannabidiol market to be worth more than $89bn by 2026

Cannabidiol market to be worth more than $89bn by 2026

A report published by Global Market Insights, Inc., shows that the cannabidiol market size is expected to surpass $89.0bn in revenue by 2026. The report...
Boosting mental health: patent filed for Omega-3 and CBD formulation

Boosting mental health: patent filed for Omega-3 and CBD formulation

CanaQuest has filed a provisional Omega-3 and CBD formulation patent which aims to help address mental health. CanaQuest, a company developing unique health products and...
Evidence CBD may reduce cytokine storm and inflammation in COVID-19

Evidence CBD may reduce cytokine storm and inflammation in COVID-19

A new study has revealed early evidence that CBD may help to reduce cytokine storms and excessive lung inflammation in patients with COVID-19. Carried out...

Latest MCN Publication

Medical Cannabis Network Quarterly Issue 3

Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis. Welcome...

EVENT PARTNERS

Pin It on Pinterest